PRECISE-AFMR I: Transcatheter Mitral Valve Edge-to-Edge Repair for Atrial Functional Mitral Regurgitation in Patients at High Surgical Risk
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 182 participants.
Also called NCT07741253
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 182 participants
- Sponsor
- Registry
-
NCT07741253
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07741253. Randomized; single masking; primary purpose treatment. Start 2026-10-25 (anticipated); primary completion 2027-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- PRECISE-AFMR I: Transcatheter Mitral Valve Edge-to-Edge Repair for Atrial Functional Mitral Regurgitation in Patients at High Surgical Risk
- Acronym
- PRECISE-AFMR I
- Condition
- Atrial Functional
- Condition
- Mitral Regurgitation (MR)
- Intervention (Device)
- Transcatheter Edge-to-Edge Repair
- Lead sponsor
- China National Center for Cardiovascular Diseases
- Collaborator
- Chinese Academy of Medical Sciences, Fuwai Hospital
Record details
- Record id
cardio:ct-nct07741253- Content hash
a61425dc565232e850902c8d60ca03974469096cf4b1f9d098e8d9ee2377af53